FDA Panel Takes Aim at SSRI Use During Pregnancy

(Medage today) – Women should be better informed of the potential risks of the use of selective serotonin reuptake inhibitors (ISRS) during pregnancy, and these risks should be weighed with their advantages, most speakers on a selected FDA panel …